Comprehensive Analysis of 2-Hydroxy-4-Chlorobenzaldehyde COA Specifications for Pharmaceutical Intermediates
- [Synthetic Fidelity]: Validated melting point ranges (45-49°C) and isomer control for consistent reaction outcomes.
- [Procurement Velocity]: Secure tonnage quantities with factory-direct logistics and inert gas packaging protocols.
- [Regulatory Alignment]: Full documentation support including batch-specific COA, SDS, and REACH compliance data.
In the landscape of fine chemical synthesis, the reliability of raw materials dictates the success of downstream drug development. 2-hydroxy-4-chlorobenzaldehyde (CAS: 2420-26-0) serves as a critical building block for complex heterocyclic systems, including benzodiazepine diones and neuropeptide Y5 receptor antagonists. For process chemists and procurement officers, understanding the Certificate of Analysis (COA) specifications is not merely a formality but a requirement for maintaining industrial purity and batch-to-batch consistency.
As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. adheres to rigorous quality control frameworks to ensure that every shipment meets the demanding standards of the pharmaceutical industry. This technical overview dissect the critical quality parameters, synthesis considerations, and supply chain advantages associated with this essential pharmaceutical intermediate.
Interpreting COA Specifications for 2-Hydroxy-4-Chlorobenzaldehyde
The Certificate of Analysis is the primary document verifying the chemical identity and purity of the material. For 4-chlorosalicylaldehyde, specific physical constants must be validated against pharmacopeial or internal standards to ensure suitability for scale-up. Deviations in melting point or assay percentage can indicate the presence of regioisomers or incomplete reaction conversion, which may complicate downstream purification.
Key parameters typically scrutinized during incoming quality control include:
- Assay (Purity): Commercial grades typically require >98.0% purity by GC or HPLC to minimize impurity carryover.
- Melting Point: A sharp range between 45.0°C and 49.0°C indicates high crystallinity and low solvent retention.
- Appearance: Off-white to pale brown solid; significant discoloration may suggest oxidation or thermal degradation.
- Residual Solvents: Compliance with ICH Q3C guidelines for solvents used during the synthesis route, such as acetone or ethyl acetate.
When sourcing high-purity 4-Chloro-2-hydroxybenzaldehyde, buyers should request batch-specific chromatograms to verify the absence of the 5-chloro isomer, which can exhibit similar physical properties but different reactivity profiles.
Quality Assurance Protocols for Pharmaceutical Intermediate Grades
Maintaining quality assurance extends beyond the initial synthesis. For executive stakeholders, the stability of the supply chain and the regulatory posture of the supplier are paramount. NINGBO INNO PHARMCHEM CO.,LTD. implements robust storage protocols to prevent degradation, as this hydroxybenzaldehyde derivative is sensitive to oxidation and moisture.
Standard operating procedures for bulk storage involve maintaining the material under inert gas (nitrogen or argon) at controlled temperatures (2-8°C). This precaution preserves the integrity of the aldehyde functionality, preventing the formation of carboxylic acid impurities over time. Furthermore, our manufacturing process is designed to scalability, ensuring that lab-scale purity profiles are replicated in tonnage quantities without compromising yield or safety.
| Parameter | Specification Standard | Test Method |
|---|---|---|
| CAS Number | 2420-26-0 | Registry Verification |
| Molecular Formula | C7H5ClO2 | Elemental Analysis |
| Molecular Weight | 156.57 g/mol | Calculated |
| Purity (Assay) | > 98.0% | GC / HPLC |
| Melting Point | 45.0 - 49.0 °C | DSC / Capillary |
| Storage Condition | Inert Gas, 2-8°C | Warehouse Protocol |
Batch Consistency and Impurity Profile Analysis
For R&D teams, the impurity profile is often more critical than the absolute purity percentage. The synthesis of this compound typically involves the formylation of 3-chlorophenol. Inefficient process control can lead to variable levels of unreacted phenol or over-formylated byproducts. Advanced manufacturing processes utilize optimized catalytic systems to maximize yield while suppressing side reactions.
Consistency in the impurity profile ensures that downstream reactions, such as condensation or cyclization steps, proceed with predictable kinetics. Variability here can lead to failed batches in final drug substance production, resulting in significant financial loss. Therefore, partnering with a reliable fine chemical supplier who provides detailed impurity logs is essential for risk mitigation.
To ensure your production lines remain efficient and compliant, contact our technical sales team for a batch-specific COA, SDS, or bulk pricing quote. We are committed to supporting your development timelines with reliable supply and transparent technical data.